山鷹國際(600567.SH):全資子公司轉讓產業併購基金份額
格隆匯9月10日丨山鷹國際(600567.SH)公佈,2024年9月10日,全資子公司山鷹私募與受讓方簽署了《嘉興英凰股權投資合夥企業(有限合夥)合夥份額轉讓協議》,約定山鷹私募以人民幣53,913.33萬元將其持有的39,500.00萬元產業併購基金實繳份額轉讓給受讓方。轉讓價款分兩期支付,受讓方應於2024年10月31日前支付第一期轉讓價款27,463.35萬元,於2024年11月15日前支付第二期轉讓價款26,449.98萬元。因合夥份額轉讓而產生的税負,由雙方根據相關法律法規的規定自行承擔。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.